Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States-Reference-Cited by-同舟云学术

Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States

Published:2013-10 Issue:10 Volume:35 Page:1501-1512
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bonafede Machaon M.,Johnson Barbara H,Wenten Madé,Watson Crystal

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. National Multiple Sclerosis Society. Just the Facts Brochure. 2012. http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/faqs-about-ms/download.aspx?id=22. Accessed November 9, 2012.

2. Treatment update in multiple sclerosis;Morris;Curr Allergy Asthma Rep,2012

3. Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?;Prosperini;BMC Neurol,2011

4. Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis;Stuart;Neurology,2004

5. Uitdehaag BMJ. Drug treatment of multiple sclerosis;Polman;BMJ,2000

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of clinical, utilization, and cost outcomes between oral treatments for multiple sclerosis;Journal of Managed Care & Specialty Pharmacy;2024-02-03

2. Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020;JAMA Neurology;2023-08-01

3. A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy;Multiple Sclerosis and Related Disorders;2022-07

4. Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis;BMC Neurology;2022-06-07

5. A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector;Neurology and Therapy;2022-01-22